dsdsa ua

khoom

High Purity 540737-29-9 Tofacitinib citrate rau JAK Pathway Inhibitor

Lus piav qhia luv luv:


  • Purity:≧99.0%
  • Txuj Txuj Ci:Enterprise Standard los yog raws li xav tau
  • Muaj peev xwm:35Kgs / hli
  • Lub neej txee:Peb xyoos
  • Daim ntawv thov:Kho rheumatoid mob caj dab, psoriatic mob caj dab, ankylosing spondylitis thiab ulcerative colitis
  • Pab Pawg Advantage:Kev paub export pab neeg muag khoom nrog kev cob qhia hauv lub hoobkas
  • Product Detail

    FAQ

    Khoom cim npe

    Khoomnpe Tofacitinib Citrate
    Synonyms (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3 -propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
    CAS Nr. 540737-29-9
    Qhov tshwm sim Tawm dawb mus rau dawb hmoov
    Molecular Formula C16H20N6OC6H8O7
    Molecular Luj 504.50 Nws
    Daim ntawv thov Pharmaceutical qib lossis lub hom phiaj tshawb fawb
    Ntim Raws li koj qhov kev thov
    Cia Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias

     

    Tofacitinib Citrate (CAS #540737-29-9)

    Yam khoom

    STANDARDS

    TSEEM CEEB

    Qhov tshwm sim

    Tawm dawb mus rau dawb hmoov

    Tawm hmoov dawb

    Kev txheeb xyuas

    HPLC;IR;HNMR

    Ua raws

    Solubility

    Soluble hauv DMSO ntawm 100mg / ml, tsis zoo soluble hauv ethanol, sparingly soluble hauv dej thiab lwm yam.

    Ua raws

    Poob rau ziab

    ≤ 0.5%

    0.12%

    Residue ntawm ignition

    ≤0.1%

    0.05%

    Cov hlau hnyav

    ≤10ppm

    Ua raws

    Yam khoom muaj feem

    Kev kub ntxhov (RS + SR) ≤0.1%

    Ib qho impurity ≤0.15%

    Tag nrho impurities ≤1.0%

    0.05%

    0.14%

    0.18%

    Enantiomorphism Isomers

    ≤ 0.2%

    Ua raws

    Residual Solvents

    Ethanol ≤5000ppm

    Methanol ≤3000ppm

    Toluene ≤890ppm

    Ua raws

    Citrate Cov ntsiab lus

    36.2% ~ 40%

    37.8%

    Purity

    ≥99.0%

    99.38%

    Assay

    60.68% ~ 63.16% ntawm Tofacitinib INN

    98% ~ 102% ntawm Tofacitinib Citrate INN

    62.04%

     

    99.12%

    Xaus: Ua raws

    Cov ntaub ntawv tuam txhab

    √ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm;
    √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system;
    √ 11 xyoo dhau los ntawm pab pawg muag khoom;
    √ Kev ywj pheej R & D lab;
    √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia;
    √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized;
    √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.
    imgsaf uaSDGSHDASFG

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb